Price Alert

InMed Pharmaceuticals Inc... (INM)

NASDAQ: INM · Real-Time Price · USD

2.29

0.03 (1.33%)

At close: Oct 03, 2025, 3:59 PM

2.24

-2.18%

After-hours: Oct 03, 2025, 06:47 PM EDT

InMed Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Net Income	-5.99M	-7.68M	-7.95M	-18.6M	-10.2M
Depreciation & Amortization	392.48K	604.52K	596K	511.79K	120.87K
Stock-Based Compensation	87.57K	137.71K	278.15K	697.89K	610.19K
Other Working Capital	-187.82K	-435.56K	16.17K	-687.51K	-490.65K
Other Non-Cash Items	57.45K	316.82K	-803	4.46M	374.23K
Deferred Income Tax	n/a	n/a	356.89K	n/a	-242.39K
Change in Working Capital	-247.47K	-369.34K	-565.82K	-2.73M	-450.45K
Operating Cash Flow	-5.7M	-6.99M	-7.28M	-15.58M	-9.79M
Capital Expenditures	n/a	-9.29K	-161.8K	-39.11K	-1.73K
Cash Acquisitions	n/a	n/a	-500K	-208.89K	n/a
Purchase of Investments	31.02K	-42.08K	-42.27K	-425K	n/a
Sales Maturities Of Investments	-31.02K	42.08K	42.27K	425K	n/a
Other Investing Acitivies	n/a	-9.29K	-501.79K	-425K	0.00
Investing Cash Flow	n/a	-9.29K	-661.8K	-673K	-1.73K
Debt Repayment	n/a	n/a	n/a	-290.83K	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	3.69M	n/a	646.00	-1.78M	-1.62M
Financial Cash Flow	9.01M	4.65M	10.68M	15.07M	10.85M
Net Cash Flow	3.31M	-2.34M	2.74M	-1.19M	1.56M
Free Cash Flow	-5.7M	-7M	-7.45M	-15.62M	-9.79M